ClinicalTrials.gg
RecruitingNCT07519928Updated Apr 15, 2026

Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for People With Spinal Cord Injury

An interventional study of Pelvic Floor Muscle Physiotherapy in Spinal Cord Injuries (SCI), sponsored by University of British Columbia. Recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 44 studies in Spinal Cord Injuries by University of British Columbia — 16 open to participants now, 18 under way, none of them phase 3. Spinal Cord Injuries · University of British Columbia.

Planned enrollment
4th of 38
50 · median 22
Started
2026
with 4 others
No phase
31 of 44
13 open now
Primary completion
2027-09
later than 10 of 17 live
Registered
42nd of 44
by date

Among the 44 studies in Spinal Cord Injuries by University of British Columbia, this one is the 4th largest by planned enrollment of the 38 interventional ones that give a count, is one of 5 that started in 2026, is one of 31 with no phase, reaches primary completion later than 10 of the 17 other live ones, and was the 42nd registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

16 of the 44 studies in Spinal Cord Injuries by University of British Columbia are open now, in 2 countries. Recruiting first, the newest first:

10 more — sign in →

By country, each count listing its studies:

All 16 open studies →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Spinal Cord Injuries by University of British Columbia, or all of them as a file.
02

Study summary

The goal of this clinical study is to determine the feasibility and explore the potential benefits of pelvic floor muscle training during inpatient SCI rehabilitation on urinary, bowel, and sexual function and quality of life in people with SCI. The main questions it aims to answer are:

  1. What is the feasibility of recruiting inpatients from SCI rehabilitation to a pelvic floor muscle training program?
  2. What is the feasibility and acceptance of the implementation of a pelvic floor muscle training program in SCI inpatient rehabilitation?
  3. What are the potential effects of a pelvic floor muscle training program implemented in SCI inpatient rehabilitation on bladder, bowel, and sexual function and quality of life?

Participants will be asked to complete a series of assessments (questionnaires, physical assessments) before and after a 6-week intervention of pelvic floor physical therapy.

03

Conditions studied

  • Spinal Cord Injuries (SCI)

Keywords

  • Spinal Cord Injury
  • Physiotherapy
  • Physical Therapy
  • Pelvic Floor Muscles
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Are at least 19 years of age.
  2. Have a traumatic or non-traumatic SCI
  3. Are able to perform a voluntary anal contraction
  4. Present with bladder or urinary tract dysfunction from SCI
  5. Are a current inpatient at GF Strong Rehabilitation Center and are expected to remain as an inpatient for at least 6 weeks after the time of consent.
  6. Are able to speak and understand English.

Exclusion criteria

Exclusion Criteria:

  1. Present with symptoms of lower motor neuron injury to the sacral segments (e.g. negative anal and bulbocavernosus reflexes)
  2. Present with any other condition besides SCI that impacts the pelvic floor muscles or other pelvic structures
  3. Are planning to receive intra-detrusor Botox injections in the next 3 months
  4. Have a brain injury or other condition that interferes with their ability to follow instructions
  5. Are using a ventilator
  6. Have severe and unmanaged spasticity (involuntary muscle tightness or spasms) or contractures (prolonged muscle/joint stiffness)
  7. Are unable to tolerate transfers to or lie on a physical therapy table
  8. Experience severe pain that interferes with their ability to participate in pelvic floor muscle training
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Pelvic Floor Muscle Physical Therapy

    Pelvic floor muscle physical therapy 5/week for 6 weeks.

    Behavioral: Pelvic Floor Muscle Physiotherapy

Interventions

  • BehavioralPelvic Floor Muscle Physiotherapy

    Pelvic floor muscle physiotherapy 5x/week for 6-weeks.

06

What researchers measure

Primary outcomes

  1. Feasibility - Recruitment Rate

    Recruitment Rate will be evaluated by the number of participants approached, screened for eligibility, and invited to enroll in the study, relative to the number of overall inpatients admitted to the GF Strong Rehabilitation Center SCI unit. We will document the number of participants who enrolled, declined enrollment, or did not respond to our invitation to enroll, as well as the reasons for not enrolling when available.

    Time frame: Through study completion, an average of 8 months

  2. Feasibility - Compliance

    Compliance will be tracked by the number of participants who underwent the intervention, as well as their adherence to the prescribed exercise program (attendance to supervised sessions and diaries), with reasons for missed sessions or drop-outs noted.

    Time frame: Through study completion, an average of 8 months

  3. Feasibility - Acceptability (Perceived Acceptability Questionnaire)

    Acceptability of the intervention will be assessed using a study-specific questionnaire, the Perceived Acceptability Questionnaire, developed for this study. The questionnaire aims to capture participants' enjoyment of the PFMT program and their perceptions of its benefits for urinary, bowel, and sexual health. Each item is rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree), with higher scores reflecting greater perceived acceptability and benefit.

    Time frame: Through study completion, an average of 8 months

Secondary outcomes

  1. Incontinence Quality of Life Questionnaire (I-QoL)

    Participants will be asked to respond to 22 questions about how urinary incontinence impacts their quality of life using a 5-point scale with values ranging from 1 (extremely) to 5 (not at all). The questionnaire probes three subdomains of how incontinence may affect quality of life: avoidance and limiting behaviour, psychosocial impact, and social embarrassment. The total score on this questionnaire ranges from 0 to 100, with higher scores indicating a higher quality of life.

    Time frame: Through study completion, an average of 8 months

  2. Neurogenic Bladder Symptoms Score (NBSS)

    Participants will be asked to respond to 24 questions regarding the severity of their bladder symptoms secondary to neurological injury. Questions cover three subdomains: incontinence, storage and voiding, and consequences. The total score on this questionnaire ranges from 0 to 74, with lower scores indicating less severe symptoms.

    Time frame: Through study completion, an average of 8 months

  3. Timed Bowel Routine

    Participants will be asked how long their bowel movements take, and what (if any) aids they used to complete the bowel movement (e.g. suppository, laxatives, digital stimulation/evacuation, help of another person, etc.).

    Time frame: Through study completion, an average of 8 months

  4. Neurogenic Bowel Dysfunction Score (NBDS)

    Participants will be asked to complete the NBDS questionnaire, which asks 11 questions to clinically assess the severity of their bowel dysfunction symptoms. The total score on this questionnaire ranges from 0 to 47, with higher scores indicating greater bowel dysfunction symptoms.

    Time frame: Through study completion, an average of 8 months

  5. International Index of Erectile Function (IIEF) Questionnaire

    Male participants will be asked to complete the IIEF questionnaire which askes 15 questions to clinically assess sexual health in 5 domains, each with their own score range: erectile function (0-30), orgasmic function (0-10), sexual desire (0-10), intercourse satisfaction (0-15), overall satisfaction (0-10). A lower score represents greater dysfunction or dissatisfaction in any of the subdomains.

    Time frame: Through study completion, an average of 8 months

  6. Female Sexual Function Index (FSFI) Questionnaire

    Female participants will be asked to complete the FSFI questionnaire, which asks 19 questions to clinically assess sexual health in 6 domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. The total score on this questionnaire ranges from 0 to 36, with lower scores indicating greater dysfunction, dissatisfaction, or pain.

    Time frame: Through study completion, an average of 8 months

  7. Sexual Quality of Life Questionnaire - Male/Female (SQoL)

    Participants will complete the sex-specific version of this questionnaire corresponding to their sex. The male version includes 11 items and the female version includes 18 items, with respondents rating their level of agreement or disagreement with each statement. Total scores range from 11 to 66 for males and 18 to 108 for females. In both versions, lower scores reflect poorer sexual quality of life.

    Time frame: Through study completion, an average of 8 months

  8. S4/5 Questionnaire

    Participants will be asked to complete a brief questionnaire that asks about their sensation at the S4/5 dermatomes (near and just inside the anal canal), and their ability to perform voluntary anal contractions. This questionnaire is not scored and will be reported descriptively.

    Time frame: Through study completion, an average of 8 months

  9. Pelvic Floor Electromyography

    PFM function (i.e., endurance and motor control) will be assessed using surface electromyography (EMG). Two pairs of disposable EMG electrodes will be placed perianally to record bilaterally from the pelvic floor. Additional surface EMG sensors will be placed bilaterally over other muscles of the core (e.g. abdominals, glutes). Participants will be instructed to attempt a maximal, isolated PFM contraction (Kegel). The research team will provide standardized, sex-specific instructions for performing this movement. If the participant can perform an isolated PFM contraction, we will assess their motor control by asking them to perform a series of rapid contract-relax cycles. We will also assess endurance by asking them to try to hold a PFM contraction for up to 1 minute. All maneuvers may be recorded up to 3 times.

    Time frame: From enrollment to the end of treatment at 6-weeks, or discharge from inpatient care

  10. Ultrasound Assessment

    The PFM function will be assessed through transperineal ultrasound. An ultrasound probe will be placed on the perineum to visualize the pelvic floor and other relevant pelvic structures (e.g. bladder, urethra, vaginal canal, sphincters, pelvic bones). Ultrasound images and recordings will be obtained while the participant is at rest and during PFM contractions.

    Time frame: From enrollment to the end of treatment at 6-weeks, or discharge from inpatient care

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Sep 2027, 17 months later.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 17 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 2, 2026
First posted
Apr 9, 2026
StartEst.
Apr 1, 2026
Primary completionEst.
Sep 30, 2027
CompletionEst.
Mar 31, 2028
Last update
Apr 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07519928
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Tania Lam (Professor, University of British Columbia) — Principal investigator
First posted
Apr 9, 2026
Start date
Apr 1, 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Mar 31, 2028 (estimated)
Last update
Apr 15, 2026

Study contacts

Jiho Song
Contact
lamlab@icord.org
604-675-8815

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion